Abstract:The rising levels of type 2 diabetes mellitus (T2DM) and the poor medical effects of the commercially available antidiabetic drugs necessitate the development of potent analogs to treat this multifactorial metabolic disorder. It has been demonstrated that targeting two or more biochemical targets associated with the onset and progression of diabetes along with oxidative stress and/or cancer could be a significant strategy for treating complications related to this metabolic disorder. The 3,5-dibromo-4,6-dimethoxychalcones (2a–f) and the corresponding flavone derivatives (3a–f) were synthesized and characterized using spectroscopic (NMR, HR-MS and FT-IR) techniques. The inhibitory effect of both series of compounds against α-glucosidase and α-amylase was evaluated in vitro through enzymatic assays. Selected compounds were also evaluated for potential to activate or inhibit superoxide dismutase. Compound 3c was selected as a representative model for the flavone series and evaluated spectrophotometrically for potential to coordinate Cu(II) and/or Zn(II) ions implicated in the metal-catalyzed free radical generation. A plausible mechanism for metal-chelation of the test compounds is presented. Furthermore, the most active compounds from each series against the test carbohydrate-hydrolyzing enzymes were selected and evaluated for their antigrowth effect on the human breast (MCF-7) and lung (A549) cancer cell lines and for cytotoxicity against the African Green Monkey kidney (Vero) cell line. The parent chalcone 2a and flavone derivatives 3a, 3c and 3e exhibited relatively high inhibitory activity against the MCF-7 cells with IC50 values of 4.12 ± 0.55, 8.50 ± 0.82, 5.10 ± 0.61 and 6.96 ± 0.66 μM, respectively. The chalcones 2a and 2c exhibited significant cytotoxicity against the A549 cells with IC50 values of 7.40 ± 0.67 and 9.68 ± 0.80 μM, respectively. Only flavone 3c exhibited relatively strong and comparable cytotoxicity against the MCF-7 and A549 cell lines with IC50 values of 6.96 ± 0.66 and 6.42 ± 0.79 μM, respectively. Both series of compounds exhibited strong activity against the MCF-7 and A549 cell lines compared to the analogous quercetin (IC50 = 35.40 ± 1.78 and 35.38 ± 1.78 μM, respectively) though moderate compared to nintedanib (IC50 = 0.53 ± 0.11 and 0.74 ± 0.15 μM, respectively). The test compounds generally exhibited reduced cytotoxicity against the Vero cells compared to this anticancer drug. Molecular docking revealed strong alignment of the test compounds with the enzyme backbone to engage in hydrogen bonding interaction/s and hydrophobic contacts with the residues in the active sites of α-glucosidase and α-amylase. The test compounds possess favorable drug-likeness properties, supporting their potential as therapeutic candidates against T2DM.

Antioxidant and anticancer activity of 3‘‐formyl‐4’, 6‘‐dihydroxy‐2’‐methoxy‐5‘‐methylchalcone and (2S)‐8‐formyl‐5‐hydroxy‐7‐methoxy‐6‐methylflavanone

A New Flavan-3-ol Lactone and Other Constituents from Euonymus Alatus with Inhibitory Activities on Α-Glucosidase and Differentiation of 3T3-L1 Cells.

Flavonoids from Vigna Angularis – Composition and Antioxidative Effects

Two New Flavones from Uvaria macrophylla Roxb. var. microcarpa and Their Cytotoxic Activities.

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Synthesis and Antiproliferative Activity of Natural and Non-Natural Polymethoxychalcones and Polymethoxyflavones

Two New Isoprenoid Flavonoids from Sophora flavescens with Antioxidant and Cytotoxic Activities

Antiproliferative Activity of Flavonoids: Influence of the Sequential Methoxylation State of the Flavonoid Structure

3,5-Dimethyl-h-7-furo[3,2-g]chromen-7-one As A Potential Anticancer Drug by Inducing P53-Dependent Apoptosis in Human Hepatoma Hepg2 Cells

Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential

Synthesis and antiproliferative activities of polymethoxyflavones aminoalkyl and amino acid derivatives

The antitumor activities of flavonoids

Flavonoid 4,4′-Dimethoxychalcone Suppresses Cell Proliferation Via Dehydrogenase Inhibition and Oxidative Stress Aggravation

In Vitro Anti-Tumor Activity of 2,4 '-Dihydroxy-6 '-Methoxy-3 ',5 '-Dimethylchalcone Against Six Established Human Cancer Cell Lines

Two New Polymethoxylated Flavones, A Class of Compounds with Potential Anticancer Activity, Isolated from Cold Pressed Dancy Tangerine Peel Oil Solids

Synthesis of selenophene‐containing flavonols and 2‐styrylchromones: Evaluation of their activities compared with selenophene‐containing chalcones as potential anticancer agents

Cytotoxic Flavonoids from the Leaves and Twigs of Murraya tetramera

Studies of the Synthesis and the Structure-activity Relationship of 3-Methylflavones

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Synthesis and in vitro and in vivo biological evaluation of novel derivatives of flexicaulin A as antiproliferative agents